Chemed Corp (CHE): Price and Financial Metrics


Chemed Corp (CHE): $476.02

5.21 (+1.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CHE POWR Grades


  • CHE scores best on the Quality dimension, with a Quality rank ahead of 98.11% of US stocks.
  • CHE's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
  • CHE's current lowest rank is in the Growth metric (where it is better than 21.63% of US stocks).

CHE Stock Summary

  • Chemed Corp's stock had its IPO on January 1, 1986, making it an older stock than 92.76% of US equities in our set.
  • Of note is the ratio of Chemed Corp's sales and general administrative expense to its total operating expenses; 98.42% of US stocks have a lower such ratio.
  • The volatility of Chemed Corp's share price is greater than that of merely 4.59% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Chemed Corp, a group of peers worth examining would be SSTK, VIPS, ACA, LGIH, and VNDA.
  • Visit CHE's SEC page to see the company's official filings. To visit the company's web site, go to www.chemed.com.

CHE Valuation Summary

  • In comparison to the median Healthcare stock, CHE's price/earnings ratio is 31.47% lower, now standing at 23.3.
  • CHE's price/sales ratio has moved up 3.2 over the prior 243 months.
  • CHE's price/sales ratio has moved up 3.2 over the prior 243 months.

Below are key valuation metrics over time for CHE.

Stock Date P/S P/B P/E EV/EBIT
CHE 2021-07-12 3.7 8.3 23.3 18.4
CHE 2017-09-20 1.9 6.7 45.3 30.3
CHE 2013-07-29 0.9 2.8 15.9 9.2
CHE 2011-12-23 0.8 2.4 12.5 7.9
CHE 2010-08-19 0.9 2.3 15.4 9.0
CHE 2008-08-07 0.9 2.8 13.7 9.8

CHE Growth Metrics

  • Its year over year cash and equivalents growth rate is now at 625.9%.
  • The 4 year revenue growth rate now stands at 27.95%.
  • Its 2 year price growth rate is now at 37.79%.
CHE's revenue has moved up $364,355,000 over the prior 34 months.

The table below shows CHE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 2,091.145 506.682 328.975
2020-12-31 2,079.583 489.289 319.466
2020-09-30 2,068.618 466.016 271.294
2020-06-30 2,020.934 470.164 262.519
2020-03-31 1,992.319 316.99 231.147
2019-12-31 1,938.555 301.249 219.923

CHE Price Target

For more insight on analysts targets of CHE, see our CHE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $576.00 Average Broker Recommendation 1.38 (Strong Buy)

CHE Stock Price Chart Interactive Chart >

Price chart for CHE

CHE Price/Volume Stats

Current price $476.02 52-week high $560.00
Prev. close $470.81 52-week low $417.41
Day low $469.15 Volume 138,700
Day high $477.62 Avg. volume 94,166
50-day MA $481.34 Dividend yield 0.29%
200-day MA $486.30 Market Cap 7.59B

Chemed Corp (CHE) Company Bio


Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is based in Cincinnati, Ohio.

CHE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$476.02$692.86 40%

Below please find a table outlining a discounted cash flow forecast for CHE, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Chemed Corp ranked in the 62th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 40.67%. As for the metrics that stood out in our discounted cash flow analysis of Chemed Corp, consider:

  • The company's debt burden, as measured by earnings divided by interest payments, is 234.24; that's higher than 95.03% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet reveals debt to be 2% of the company's capital (with equity being the remaining amount). Approximately just 9.42% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • CHE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 54.56% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%37%
1%39%
2%40%
3%41%
4%43%
5%44%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CHE, try HCSG, INCY, SGRY, MGLN, and SYNH.


CHE Latest News Stream


Event/Time News Detail
Loading, please wait...

CHE Latest Social Stream


Loading social stream, please wait...

View Full CHE Social Stream

Latest CHE News From Around the Web

Below are the latest news stories about Chemed Corp that investors may wish to consider to help them evaluate CHE as an investment opportunity.

Chemed Corporation (CHE) Q2 2021 Earnings Call Transcript

CHE earnings call for the period ending June 30, 2021.

The Motley Fool | July 28, 2021

Chemed (CHE) Q2 Earnings & Revenues Top Estimates, Margins Up

Chemed (CHE) reports better-than-expected earnings and revenues with strong Roto-Rooter segment performance driving the top line in second-quarter 2021.

Yahoo | July 28, 2021

Chemed Reports Second-Quarter 2021 Results - Full-Year 2021 Guidance Increased

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation Second-Quarter 2021 Earnings

Business Wire | July 27, 2021

Chemed Corp Consensus Indicates Potential 20.1% Upside

Chemed Corp found using ticker (CHE) now have 4 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 605 and 515 with a mean TP of 576. Given that the stocks previous close was at 479.78 this would indicate that there is a potential upside of 20.1%. The 50 day moving average now sits at 478.16 and the 200 day moving average is 482.54. The company has a market cap of $7,623m. Visit the company website at: /> [stock_market_widget type="chart" symbol="CHE" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and vol...

DirectorsTalk | July 27, 2021

Analysts Estimate Report : What to Look Out for Chemed (NYSE:CHE)

Earnings results for Chemed , Analyst Opinion on Chemed , Earnings and Valuation of (NYSE:CHE), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Analysts Estimate Report : What to Look Out for Chemed (NYSE:CHE) appeared first on .

Stock Market Daily | July 27, 2021

Read More 'CHE' Stories Here

CHE Price Returns

1-mo -2.00%
3-mo -1.22%
6-mo -7.04%
1-year -3.01%
3-year 50.45%
5-year 234.80%
YTD -10.50%
2020 21.59%
2019 55.58%
2018 17.01%
2017 52.32%
2016 7.89%

CHE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CHE Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9827 seconds.